[ Price : $8.95]
Tonix Pharmaceuticals gains approval for Tonmya (cyclobenzaprine HCl sublingual tablets), a once-daily, non-opioid drug for treati...[ Price : $8.95]
Staffing cuts and other administrative disorders leads to a review extension on a clinical hold review on Neurizon Therapeutics N...[ Price : $8.95]
FDA issues an alert on all Baxter Novum IQ Large Volume Pumps and Novum IQ Syringe Pumps after becoming aware of a company notific...[ Price : $8.95]
FDA extends by three months its review of an Omeros resubmitted BLA for narsoplimab in hematopoietic stem cell transplant-associat...[ Price : $8.95]
FDA approves a Precigen BLA for Papzimeos (zopapogene imadenovec-drba), a non-replicating adenoviral vector-based immunotherapy fo...[ Price : $8.95]
FDA issues an alert after becoming aware that Medtronic recently sent a letter to customers recommending that certain DLP Left Hea...[ Price : $8.95]
A Phase 3 study of Pfizers investigational sickle cell disease drug inclacumab fails to meet the primary endpoint.[ Price : $8.95]
FDA grants Beam Therapeutics a Regenerative Medicine Advanced Therapy designation for BEAM-101, an investigational gene-edited cel...